Literature DB >> 22814951

Intracranial clear cell meningioma in two children with blood relations: two case reports and literature review.

Zhiqi Li1, Yi Zhang, Enming Wang, Zhiqiu Wang, Wengang Li, Shan Huang, Jun Li.   

Abstract

Intracranial clear cell meningioma (CCM) is very rare and often has an aggressive clinical course. The predilection site of intracranial CCM in children was cerebellopontine angle where represents challenging tumor resection because of the vicinity of brainstem, vertebral artery, and lower cranial nerve. Therefore, special consideration is required for this tumor.We report two cases with intracranial CCM in a family and reviewed the literature concerning pediatric intracranial CCM. Case 1 is a 4-year-old boy with a tumor at the right posterior fossa. Case 2 is an 8-year-old boy with a left basilar region tumor. Gross total resection and subtotal resection was achieved in case 1 and case 2, respectively. Case 1 had no tumor recurrence at 12 months after the operation. Case 2 received cyber-knife radiosurgery (CKS) after subtotal resection at 4 months, and the residual tumor had gradually shrunk. Comprehensive chromosomal number aberrations in both patients were revealed by array-comparative genomic hybridization, and loss of neurofibromatosis 2 (NF2) gene was the common genetic abnormality in the two patients.To the best of our knowledge, this is the first report concerned two patients with CCM in a family, and the findings in this article suggest that CKS is a safe and effective adjuvant therapy for residual CCM after operation and NF2 gene mutation plays a role in tumorigenesis of pediatric intracranial CCM.

Entities:  

Mesh:

Year:  2012        PMID: 22814951     DOI: 10.1007/s00381-012-1840-7

Source DB:  PubMed          Journal:  Childs Nerv Syst        ISSN: 0256-7040            Impact factor:   1.475


  38 in total

1.  Clear cell meningioma with frequent chordoid features and aggressive behavior: a clinicopathologic study of ten cases at a single institution.

Authors:  Han-Ku Chen; You-Ting Wu; Yu-Jun Lin; Jui-Wei Lin
Journal:  J Neurooncol       Date:  2010-09-25       Impact factor: 4.130

2.  Analysis of factors affecting the long-term functional outcome of patients with skull base meningioma.

Authors:  Naoyuki Nakao; Toshika Ohkawa; Junichirou Miki; Hiroki Nishibayahsi; Mitsuhiro Ogura; Yuji Uematsu; Toru Itakura
Journal:  J Clin Neurosci       Date:  2011-05-11       Impact factor: 1.961

3.  The role of radical microsurgical resection in multimodal treatment for skull base meningioma.

Authors:  Tsutomu Ichinose; Takeo Goto; Kenichi Ishibashi; Toshihiro Takami; Kenji Ohata
Journal:  J Neurosurg       Date:  2010-03-12       Impact factor: 5.115

Review 4.  Meningiomas of the basal posterior fossa. Surgical experience in 80 cases.

Authors:  R D Lobato; P Gonzaáez; R Alday; A Ramos; A Lagares; J F Alen; J C Palomino; P Miranda; A Perez-Nuñez; I Arrese
Journal:  Neurocirugia (Astur)       Date:  2004-12       Impact factor: 0.553

5.  Clear cell meningioma: a case report.

Authors:  D F Shih; J S Wang; R G Pan; H H Tseng
Journal:  Zhonghua Yi Xue Za Zhi (Taipei)       Date:  1996-06

Review 6.  Meningiomas in children and adolescents: a meta-analysis of individual patient data.

Authors:  Rishi S Kotecha; Elaine M Pascoe; Elisabeth J Rushing; Lucy B Rorke-Adams; Ted Zwerdling; Xing Gao; Xin Li; Stephanie Greene; Abbas Amirjamshidi; Seung-Ki Kim; Marco A Lima; Po-Cheng Hung; Fayçal Lakhdar; Nirav Mehta; Yuguang Liu; B Indira Devi; B Jayanand Sudhir; Morten Lund-Johansen; Flemming Gjerris; Catherine H Cole; Nicholas G Gottardo
Journal:  Lancet Oncol       Date:  2011-11-15       Impact factor: 41.316

Review 7.  The 2007 WHO classification of tumors of the central nervous system - what has changed?

Authors:  Audrey Rousseau; Karima Mokhtari; Charles Duyckaerts
Journal:  Curr Opin Neurol       Date:  2008-12       Impact factor: 5.710

8.  Clear cell meningioma. A clinicopathologic study of a potentially aggressive variant of meningioma.

Authors:  S Zorludemir; B W Scheithauer; T Hirose; C Van Houten; G Miller; F B Meyer
Journal:  Am J Surg Pathol       Date:  1995-05       Impact factor: 6.394

9.  Supratentorial clear cell meningioma in a child: A rare tumor at unusual location.

Authors:  Rakesh Ranjan; Shrividya Sethuraman
Journal:  J Pediatr Neurosci       Date:  2010-07

10.  Clear-cell meningioma: CT and MR imaging findings in two cases involving the spinal canal and cerebellopontine angle.

Authors:  Ki Bong Yu; Myung Kwan Lim; Hyung Jin Kim; Chang Hae Suh; Hyung Chun Park; Eun Young Kim; Hye Seung Han
Journal:  Korean J Radiol       Date:  2002 Apr-Jun       Impact factor: 3.500

View more
  5 in total

1.  Molecular progression in unusual recurrent non-pediatric intracranial clear cell meningioma.

Authors:  B Domingo-Arrué; R Gil-Benso; J Megías; L Navarro; T San-Miguel; L Muñoz-Hidalgo; C López-Ginés; M Cerdá-Nicolás
Journal:  Curr Oncol       Date:  2017-06-27       Impact factor: 3.677

Review 2.  Pediatric intracranial clear cell meningioma: a clinicopathological study of seven cases and literature review.

Authors:  Hao Li; Meng Zhao; Yuming Jiao; Zhicen Li; Ji Ma; Shuo Wang; Yong Cao; Jizong Zhao
Journal:  Childs Nerv Syst       Date:  2016-10-27       Impact factor: 1.475

Review 3.  Using the neurofibromatosis tumor predisposition syndromes to understand normal nervous system development.

Authors:  Cynthia Garcia; David H Gutmann
Journal:  Scientifica (Cairo)       Date:  2014-08-28

4.  Clear cell meningioma in a child: A case report and review of literature.

Authors:  Rajan Kumar; Kuntal Kanti Das; Awadhesh Kumar Jaiswal; Anant Mehrotra; Rabi Narayan Sahu; Arun Kumar Srivastava; Sushila Jaiswal; Sanjay Behari
Journal:  Asian J Neurosurg       Date:  2015 Jan-Mar

5.  Pediatric intracranial clear cell meningioma associated with a germline mutation of SMARCE1: a novel case.

Authors:  Helen Raffalli-Ebezant; Scott A Rutherford; Stavros Stivaros; Anna Kelsey; Miriam Smith; D Gareth Evans; John-Paul Kilday
Journal:  Childs Nerv Syst       Date:  2014-09-24       Impact factor: 1.475

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.